P2‐003: Clinical Trial Design of Cread: A Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Phase 3 Study to Evaluate Crenezumab Treatment in Patients with Prodromal‐To‐Mild Alzheimer's Disease. (1st July 2016)

Record Type:: Journal Article
Title:: P2‐003: Clinical Trial Design of Cread: A Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Phase 3 Study to Evaluate Crenezumab Treatment in Patients with Prodromal‐To‐Mild Alzheimer's Disease. (1st July 2016)
Main Title:: P2‐003: Clinical Trial Design of Cread: A Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Phase 3 Study to Evaluate Crenezumab Treatment in Patients with Prodromal‐To‐Mild Alzheimer's Disease
Authors:: Blaettler, Thomas
Smith, Janice
Smith, Jillian
Paul, Robert
Asnaghi, Veronica
Fuji, Reina
Quartino, Angelica
Honigberg, Lee
Rabbia, Michael A.
Yule, Susan
Ostrowitzki, Susanne
Fontoura, Paulo
Abstract:
Is Part Of:: Alzheimer's & dementia. Volume 12:Supplement 7S(2016)Part 12
Journal:: Alzheimer's & dementia
Issue:: Volume 12:Supplement 7S(2016)Part 12
Issue Display:: Volume 12, Issue 7, Part 12 (2016)
Year:: 2016
Volume:: 12
Issue:: 7
Part:: 12
Issue Sort Value:: 2016-0012-0007-0012
Page Start:: P609
Page End:: P609
Publication Date:: 2016-07-01
Subjects:: Alzheimer's disease -- Periodicals
Alzheimer Disease -- Periodicals
Dementia -- Periodicals
Démence
Maladie d'Alzheimer
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
616.83
Journal URLs:: http://www.sciencedirect.com/science/journal/15525260 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.jalz.2016.06.1207 ↗
Languages:: English
ISSNs:: 1552-5260
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 0806.255333
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 13218.xml